The Institute for Regenerative Med advances scientific innovation in regenerative medicine by supporting research, clinical translation, and public engagement initiatives. Its core mission centers on accelerating the development and dissemination of next-generation therapies through strategic investments in research infrastructure, workforce development, and stakeholder communication.
Institute for Regenerative Medical is a government agency with procurement activity across contracts, awards, and contractors. It currently has 7 open contract opportunities.
Spending trends, top contractors, industry breakdown, and recent contract activity.
AI Mission Profile
The Institute for Regenerative Med advances scientific innovation in regenerative medicine by supporting research, clinical translation, and public engagement initiatives. Its core mission centers on accelerating the development and dissemination of next-generation therapies through strategic invest...
The Institute for Regenerative Med advances scientific innovation in regenerative medicine by supporting research, clinical translation, and public engagement initiatives. Its core mission centers on accelerating the development and dissemination of next-generation therapies through strategic investments in research infrastructure, workforce development, and stakeholder communication. The agency prioritizes the design and implementation of patient-centered clinical trial platforms, public outreach to build trust in emerging therapies, and professional training to strengthen the bioscience workforce. Its programs emphasize transparency, community engagement, and the ethical advancement of regenerative technologies.
The agency procures primarily professional services to enable research communication, administrative support, and training. Contracts are awarded through competitive solicitation processes for specialized expertise in public relations, clinical trial platform development, accounting services, and management training. These procurements reflect a reliance on external vendors to supplement internal capacity in areas requiring niche technical or communicative skills, rather than direct in-house execution.
Primary procurement activity is concentrated in Public Relations Agencies (NAICS 541820), reflecting a strong emphasis on public education and stakeholder outreach around complex biomedical advancements. Additional focus areas include Research and Development in the Life Sciences (541715) for clinical trial technology and Professional and Management Development Training (611430) to build institutional capability. The agency does not utilize set-asides and engages vendors across all sizes, indicating a preference for technical proficiency and domain expertise over socioeconomic targeting.
Organized under the State of California, the Institute operates as a specialized entity within the state’s broader health and science ecosystem. It leverages standard state procurement vehicles to acquire services that support its research and public engagement mandate. With no physical location specified, its operations are likely decentralized, coordinating statewide initiatives through contractual partnerships rather than centralized infrastructure.
Recent Institute for Regenerative Medical Contracts
The latest contract opportunities posted by Institute for Regenerative Medical, including active solicitations and recent awards.
